ALKBH5 and neoplasm: The highly expressed ALKBH5 reduces the m6A modification of PVT1 to suppress the YTHDF2-mediated m6A-dependent degradation, leading to PVT1 overexpression, which results in the promotion of OS cell proliferation and tumor growth (77).